Analyst Price Targets — INMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 11, 2026 12:03 pm | Jeff Johnson | Robert W. Baird | $17.00 | $14.62 | TheFly | InMode price target raised to $17 from $16 at Baird |
| December 17, 2025 12:15 pm | — | Canaccord Genuity | $15.00 | $14.48 | TheFly | InMode price target lowered to $15 from $16 at Canaccord |
| April 14, 2025 5:13 pm | Matthew Taylor | Jefferies | $15.00 | $15.08 | TheFly | InMode price target lowered to $15 from $16 at Jefferies |
| October 16, 2024 4:06 pm | Sam Elber | BTIG | $25.00 | $16.88 | StreetInsider | BTIG Starts InMode Ltd. (INMD) at Buy |
| October 12, 2024 5:23 pm | Matt Miksic | Barclays | $27.00 | $16.50 | TheFly | InMode price target lowered to $27 from $29 at Barclays |
| July 23, 2024 5:00 am | Matthew Taylor | Jefferies | $19.00 | $17.75 | TheFly | InMode downgraded to Hold from Buy at Jefferies |
| July 12, 2024 6:30 am | Caitlin Cronin | Canaccord Genuity | $16.00 | $16.82 | TheFly | InMode price target lowered to $16 from $21 at Canaccord |
| May 3, 2024 7:06 am | Danielle Antalffy | UBS | $20.00 | $17.36 | StreetInsider | InMode Ltd. (INMD) PT Lowered to $20 at UBS |
| October 13, 2023 2:11 pm | Caitlin Cronin | Canaccord Genuity | $22.00 | $20.75 | Benzinga | InMode Faces Revenue Headwinds Amid Challenging Economics: Analyst Cuts Price Target And Estimates |
| December 21, 2022 7:00 am | — | Barclays | $44.00 | $35.22 | Benzinga | Barclays Initiates Coverage On InMode with Overweight Rating, Announces Price Target of $44 |
Latest News for INMD
Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd.
Shares of InMode Ltd. (NASDAQ: INMD - Get Free Report) have been assigned an average recommendation of "Hold" from the nine research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and one has issued a buy recommendation on
YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026.
Shares of InMode Ltd. (NASDAQ: INMD - Get Free Report) have received an average rating of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and one has assigned a buy recommendation to the
InMode Ltd. (NASDAQ: INMD - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $12.76, but opened at $13.71. InMode shares last traded at $13.5850, with a volume of 653,419 shares changing hands. Wall Street Analysts Forecast Growth A number of research firms have recently weighed in on
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INMD.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.